SEI-1 shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc. | Biocompare.com

Supplier Images

SEI-1 shRNA Plasmid (h)

Be the first to write a review!

Citations:

Supplier Page from
Santa Cruz Biotechnology, Inc. for
SEI-1 shRNA Plasmid (h)

Product Specs
ItemSEI-1 shRNA Plasmid (h)
CompanySanta Cruz Biotechnology, Inc.
Price $592.00Supplier Page View Company Product Page
Catalog Numbersc-62988-SH
Quantity20 µg
RNA TypeshRNA Clones
Vector Type (Standardized)Lentiviral
TypeshRNA Plasmid
Specieshuman
NCBI Full Gene NameSERTA domain containing 1
NCBI Gene AliasesSEI1, TRIP-Br1, TRIPBR1

Add to Compare List

Santa Cruz Biotechnology, Inc.

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) The regulation of insulin receptor/insulin-like growth factor 1 receptor ratio, an important factor for breast cancer prognosis, by TRIP-Br1Journal of hematology & oncologyJune 16, 2022Nguyen TNQ, Jung S, Nguyen HA, Lee B, Vu SH, Myagmarjav D, Eum HH, Lee HO, Jo T, Choi Y, et al.

(2) Sertad1 promotes prostate cancer progression through binding androgen receptor ligand binding domainInternational journal of cancerFebruary 1, 2019Hu B, Hu H, Yin M, Sun Z, Chen X, Li Y, Sun Z, Liu C, Li L, Qiu Y.

(3) Inhibitory role of TRIP-Br1 oncoprotein in hypoxia-induced apoptosis in breast cancer cell linesInternational journal of oncologyJune 1, 2016Li C, Jung S, Yang Y, Kim KI, Lim JS, Cheon CI, Lee MS.

(4) TRIP-Br1 oncoprotein inhibits autophagy, apoptosis, and necroptosis under nutrient/serum-deprived conditionOncotargetOctober 6, 2015Jung S, Li C, Duan J, Lee S, Kim K, Park Y, Yang Y, Kim KI, Lim JS, Cheon CI, et al.

(5) Nutrient/serum starvation derived TRIP-Br3 down-regulation accelerates apoptosis by destabilizing XIAPOncotargetApril 10, 2015Li C, Jung S, Lee S, Jeong D, Yang Y, Kim KI, Lim JS, Cheon CI, Kim C, Kang YS, et al.

(6) Oncogenic function of p34SEI-1 via NEDD4‑1‑mediated PTEN ubiquitination/degradation and activation of the PI3K/AKT pathwayInternational journal of oncologyNovember 1, 2013Jung S, Li C, Jeong D, Lee S, Ohk J, Park M, Han S, Duan J, Kim C, Yang Y, et al.

Be the First to Write a Review!